Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Communications"
DOI: 10.1002/cac2.12318
Abstract: We previously observed decreasing resection rates of non‐metastatic gastric adenocarcinoma (GaC) in the US and some European countries. If and to what extent these trends affect the trends in overall survival (OS) of patients with… read more here.
Keywords: metastatic gastric; resection rates; decreasing resection; patients non ... See more keywords
Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Medicine"
DOI: 10.1002/cam4.6578
Abstract: Intensity‐modulated radiotherapy (IMRT) combined with concurrent chemotherapy is deemed as the mainstay treatment in locoregionally advanced nasopharyngeal carcinoma (NPC). Nevertheless, the tolerance of severe acute toxicity of concurrent chemotherapy was unsatisfied. In addition, T4 is… read more here.
Keywords: concurrent chemotherapy; non metastatic; imrt; chemotherapy ... See more keywords
The interplay of KRAS mutational status with tumor laterality in non‐metastatic colorectal cancer: An international, multi‐institutional study in patients with known KRAS, BRAF, and MSI status
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26352
Abstract: Although the prognostic relevance of KRAS status in metastatic colorectal cancer (CRC) depends on tumor laterality, this relationship is largely unknown in non‐metastatic CRC. read more here.
Keywords: status; metastatic colorectal; colorectal cancer; tumor laterality ... See more keywords
The value of 18F-FDG PET/CT-based radiomics in predicting perineural invasion and outcome in non-metastatic colorectal cancer
Sign Up to like & getrecommendations! Published in 2022 at "Abdominal Radiology"
DOI: 10.1007/s00261-022-03453-0
Abstract: Perineural invasion (PNI) has been recognized as an important prognosis factor in patients with colorectal cancer (CRC). The purpose of this retrospective study was to investigate the value of 18F-FDG PET/CT-based radiomics integrating clinical information,… read more here.
Keywords: non metastatic; metastatic crc; perineural invasion; pet ... See more keywords
Relationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-018-3592-x
Abstract: PurposeThis study aimed to explore whether peak serum methotrexate concentration (Cmax) correlated with adverse events, overall survival (OS) and event-free survival (EFS) in patients with primary extremity osteosarcoma.MethodsPatients with extremity osteosarcoma who were treated at… read more here.
Keywords: methotrexate; extremity; methotrexate concentration; serum methotrexate ... See more keywords
Treatment and survival of early non-metastatic breast cancer in men: real world data from a population-based registry
Sign Up to like & getrecommendations! Published in 2025 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-025-08139-8
Abstract: This study aimed to characterize a cohort of male patients with non-metastatic breast cancer, specifically focusing on tumor characteristics, treatment strategies, and determinants of overall survival. Data for this study were obtained from the Baden-Württemberg… read more here.
Keywords: cancer; treatment; breast cancer; non metastatic ... See more keywords
The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-019-03042-7
Abstract: Purpose No study has evaluated the prognostic impact of the age-adjusted Charlson comorbidity index (AACI) in those with renal cell carcinoma (RCC). This study aimed to evaluate the utility of the AACI for predicting long-term… read more here.
Keywords: cell; charlson comorbidity; overall survival; oncology ... See more keywords
Machine learning to predict the cancer-specific mortality of patients with primary non-metastatic invasive breast cancer
Sign Up to like & getrecommendations! Published in 2020 at "Surgery Today"
DOI: 10.1007/s00595-020-02170-9
Abstract: We used five machine-learning algorithms to predict cancer-specific mortality after surgical resection of primary non-metastatic invasive breast cancer. This study was a secondary analysis of data for 1661 women with primary non-metastatic invasive breast cancer.… read more here.
Keywords: machine learning; cancer specific; cancer; non metastatic ... See more keywords
Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-019-01497-9
Abstract: To evaluate the outcomes of non-metastatic colon cancer patients in relation to the socioeconomic status (SES) at diagnosis based on the Surveillance, Epidemiology, and End Results (SEER) census tract level-SES database. SEER SES census tract… read more here.
Keywords: metastatic colon; colon cancer; cancer; cancer patients ... See more keywords
Longitudinal assessment of bone mineral density in prostate cancer patients: comparing metastatic and non-metastatic regions
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-025-02711-7
Abstract: Prostate cancer patients receiving androgen deprivation therapy (ADT) have increased risks of decreased bone mineral density (BMD). However, there are no established guidelines for assessing BMD in patients with bone metastases. The aim of this… read more here.
Keywords: bone; non metastatic; cancer patients; prostate cancer ... See more keywords
Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Targeted Oncology"
DOI: 10.1007/s11523-020-00779-x
Abstract: Oral darolutamide (Nubeqa™) is a novel second-generation, nonsteroidal, selective androgen receptor (AR) inhibitor indicated for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC). In the pivotal multinational, phase 3 ARAMIS trial in men with nmCRPC,… read more here.
Keywords: prostate; prostate cancer; metastatic castration; castration resistant ... See more keywords